Stained Glass Cross – Psychedelic Light Burst

(© João Queirós - stock.adobe.com)

New study finds clergy from major world religions reported profound spiritual experiences and improved effectiveness as religious leaders after taking the psychedelic mushroom compound.

In a nutshell

  • Religious leaders who took psilocybin reported it made them more effective at their jobs and deepened their spiritual practices rather than undermining their faith
  • 96% of participants rated the experience among the five most spiritually significant of their lives, with lasting positive effects on prayer, meditation, and interfaith appreciation
  • The study challenges assumptions that psychedelic experiences aren’t genuine spiritual encounters, as trained clergy overwhelmingly interpreted them as religiously meaningful

BALTIMORE — A Christian minister, Jewish rabbi, Muslim imam, and Buddhist monk walked into a research lab — and what happened next is turning heads in both religious and medical circles. For the first time, scientists systematically studied what happens when professionally trained religious leaders take psilocybin, the active compound in “magic mushrooms.”

The surprising results will certainly open up new paths for research when it comes to mixing psychedelics with faith. Rather than undermining their religious beliefs, the experience actually made these clergy members feel more effective in their roles and deepened their spiritual practices.

The study by researchers at Johns Hopkins University and New York University followed 29 religious leaders from Christianity, Judaism, Islam, and Buddhism through carefully supervised psilocybin sessions. Six months later, compared to a control group that hadn’t yet received the drug, those who took psilocybin reported significant improvements in their religious practices, attitudes about their faith, and effectiveness as spiritual leaders.

Nearly all participants (96%) rated their psilocybin experience as among the five most spiritually significant of their entire lives, with 42% calling it the single most profound experience they’d ever had.

Rigorous Testing Under Laboratory Conditions

Led by the late Dr. Roland Griffiths, a renowned researcher in the field of psychedelic medicine who passed away in October 2023, the study used the same rigorous safety protocols developed for medical psilocybin research. All 29 participants had never used psilocybin or similar substances before. They held recognized leadership positions in established religious organizations and had formal training or ordination in their traditions. Most were highly educated (93% had post-graduate degrees) and averaged over 22 years of professional religious experience.

Each participant received two psilocybin sessions about a month apart, taking doses of 20 to 30 milligrams based on body weight. Sessions lasted about eight hours in comfortable, living room-like settings with trained facilitators present for support.

The study, published in Psychedelic Medicine, used a “waitlist control” design, meaning half the participants received psilocybin immediately while the other half waited six months. By comparing the two groups, researchers could measure the actual effects of the drug versus normal changes over time.

Lasting Changes in Religious Practice

According to the study’s measures, 88% met the criteria for having a “complete mystical experience” during at least one of their sessions. They described profound feelings of unity, transcendence of time and space, and encounters with what they considered sacred or divine.

But the effects lasted far beyond the immediate experience. Sixteen months after their sessions, participants continued to report lasting changes in their religious lives. Most said the experience had positively affected their prayer or meditation practices and their daily sense of the sacred. Notably, 71% reported increased appreciation for religious traditions other than their own.

The researchers found that 79% of participants gave “strong or extreme” ratings when asked if their experience “enriched their contemplative, prayer, or meditation practices,” “increased their effectiveness in their spiritual/religious vocation,” and “increased their sense of the sacred in daily life.”

Refuting Long-Held Skepticism

Some scholars have long argued that psychedelic experiences aren’t genuine religious experiences but rather chemically-induced distortions that people without proper theological training might misinterpret as spiritual. By including participants with extensive religious education and training, the study directly challenges that view.

The answer turned out to be that trained religious professionals were overwhelmingly likely to interpret their experiences as genuinely spiritual and beneficial to their religious practice. Before the study, 71% had at some point seriously considered leaving religious work. After psilocybin, rates of current consideration for leaving remained low and weren’t significantly different from before the study, indicating the experience didn’t drive people away from their religious careers.

The study found no serious adverse events, though 46% of participants rated their psilocybin experience as among the five most psychologically challenging of their lives. It’s a reminder that these substances can still produce difficult experiences for people even when they’re ultimately beneficial.

Broader Questions About Faith and Science

The research builds on the famous “Good Friday Experiment” conducted in 1962, which gave psilocybin to Protestant seminary students during a religious service. That study also found lasting positive effects, but the new research is far more rigorous and includes a broader range of religious traditions.

As psychedelic medicine gains mainstream acceptance for treating conditions like depression and PTSD, questions about the relationship between these substances and spirituality become increasingly relevant. The study has significant limitations—the sample was small and predominantly white, male, and highly educated, with no representation from Indigenous religious traditions or Hinduism. Participants were also self-selected, meaning clergy willing to try psilocybin might already hold more liberal religious views than typical religious leaders.

However, if religious leaders — community pillars who often counsel others through life’s challenges — report improved effectiveness in their roles after psilocybin experiences, it raises intriguing questions about potential applications in religious education, interfaith dialogue, and spiritual care in medical settings. For centuries, humans have sought transcendent experiences through prayer, meditation, fasting, and other practices. For some religious leaders, psilocybin may be another tool in that ancient quest—one that seemed to deepen rather than diminish their faith.

Paper Summary

Methodology

Researchers studied 29 psychedelic-naïve clergy members from Christianity, Judaism, Islam, and Buddhism at Johns Hopkins University and New York University. Participants underwent extensive screening and received two supervised psilocybin sessions (20-30 mg/70 kg) about a month apart in comfortable settings with trained facilitators. The study used a randomized waitlist control design, with half the participants receiving psilocybin immediately and half waiting six months, allowing researchers to compare outcomes between groups.

Results

At six months, participants who received psilocybin reported significantly greater positive changes in religious practices, attitudes, and leadership effectiveness compared to the waitlist control group. Ninety-six percent rated their experience among the five most spiritually significant of their lives, with 42% calling it their most profound experience ever. Effects persisted at 16-month follow-up, with 79% reporting positive effects on religious practices and 71% reporting increased appreciation for other religious traditions.

Limitations

The study had a small, homogeneous sample that was primarily white, male, and highly educated. It lacked representation from many world religions and used only self-reported measures with a waitlist rather than placebo control. Participants were self-selected and may have held more liberal religious views than typical clergy. The study’s exploratory design and multiple comparisons increase the risk of statistical errors.

Funding and Disclosures

The study was funded by the CSP Fund, Turnbull Family Foundation, and RiverStyx Foundation. Several authors have financial interests in psychedelic companies or serve on advisory boards. The Johns Hopkins IRB noted issues with undisclosed funding sources and conflicts of interest that were not properly managed during the study.

Publication Information

“Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions” by Roland R. Griffiths et al., published in Psychedelic Medicine, 2025. The late Dr. Griffiths, who died in October 2023, was the lead author and a pioneering researcher in psychedelic medicine.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Reply